AstraZeneca Resumes COVID-19 Vaccine Candidate Trial in South Africa

AstraZeneca (NYSE:AZN) continues to get back on its feet after clinical trials for its coronavirus vaccine candidate were halted. On Tuesday, South Africa's Department of Health said the company had resumed the part of the trials taking place in that country.